TapewireFind a company

person · Reporting owner

HENNEMAN JOHN B III

Disclosed activity across 7 companies

Tapewire entity
36126
SEC CIK
0001187572

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Anika Therapeutics, Inc.ANIK · Entity 6005DirectorJune 18, 2026June 23, 2026
Aprea Therapeutics, Inc.APRE · Entity 7948DirectorJune 16, 2026June 17, 2026
LUMOS PHARMA, INC.(NLNK) · Entity 85102Chief Administrative OfficerOctober 01, 2018October 02, 2018
Orthofix Medical Inc.OFIX · Entity 1975DirectorJune 10, 2026June 12, 2026
R1 RCM Holdco Inc.NONE · Entity 125898DirectorJune 21, 2022June 24, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Anika Therapeutics, Inc.

Report date June 18, 2026 · Filed June 23, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect65,273 Reported balance After 2026-06-18 transaction · row 1
1 source row

Row 1 · 2026-06-18 · Grant · Acquired 10,402 · Balance 65,273

F1: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.

Filing footnotes · ownership attribution and instrument terms

F1: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.

Aprea Therapeutics, Inc.

Report date June 16, 2026 · Filed June 17, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect13,364 Reported balance After 2026-06-16 transaction · row 1
1 source row

Row 1 · 2026-06-16 · Grant · Acquired 3,135 · Balance 13,364

F1: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.73 · Expires 2036-06-16Direct12,555 Reported balance After 2026-06-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-06-16 · Grant · Acquired 12,555 · Balance 12,555

F2: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Filing footnotes · ownership attribution and instrument terms

F1: These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

F2: The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

LUMOS PHARMA, INC.

Report date October 01, 2018 · Filed October 02, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect55,052 Reported balance After 2018-10-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2018-10-01 · Tax withholding · Disposed 2,484 · Balance 55,052

F1: Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 10,198 previously reported restricted stock units ("RSUs") granted to the Reporting Person.

F2: Includes 500 RSUs previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in one installment on January 2, 2019, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

F3: Includes 8,101 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in two successive annual installments with the next installment occurring on January 4, 2019, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 10,198 previously reported restricted stock units ("RSUs") granted to the Reporting Person.

F2: Includes 500 RSUs previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in one installment on January 2, 2019, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

F3: Includes 8,101 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in two successive annual installments with the next installment occurring on January 4, 2019, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

Orthofix Medical Inc.

Report date June 10, 2026 · Filed June 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect105,774 Reported balance After 2026-06-10 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-06-10 · Grant · Acquired 14,965 · Balance 105,774

F1: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2: Includes 48,347 previously reported deferred stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

F2: Includes 48,347 previously reported deferred stock units.

R1 RCM Holdco Inc.

Report date June 21, 2022 · Filed June 24, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2022-06-21 transaction · row 1
1 source row

Row 1 · 2022-06-21 · Disposition to issuer · Disposed 54,751 · Balance 0

F1: On June 21, 2022, pursuant to the Transaction Agreement and Plan of Merger, dated as of January 9, 2022, by and among R1 RCM Holdco Inc. (f/k/a R1 RCM Inc.) (the "Company"), R1 RCM Inc. (f/k/a Project Roadrunner Parent Inc.) ("New R1"), Project Roadrunner Merger Sub Inc. ("R1 Merger Sub"), CoyCo 1, L.P., CoyCo 2, L.P. and certain other parties, R1 Merger Sub was merged with and into the Company, with the Company surviving as a direct, wholly owned subsidiary of New R1 (the "Reorganization").

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.61 · Expires 2026-02-22Direct0 Reported balance After 2022-06-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2022-06-21 · Disposition to issuer · Disposed 405,111 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F3: Option was granted under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.53 · Expires 2026-04-01Direct0 Reported balance After 2022-06-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2022-06-21 · Disposition to issuer · Disposed 12,048 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.00 · Expires 2026-07-01Direct0 Reported balance After 2022-06-21 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2022-06-21 · Disposition to issuer · Disposed 15,385 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.42 · Expires 2026-10-03Direct0 Reported balance After 2022-06-21 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2022-06-21 · Disposition to issuer · Disposed 13,762 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.29 · Expires 2027-01-03Direct0 Reported balance After 2022-06-21 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2022-06-21 · Disposition to issuer · Disposed 14,098 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.08 · Expires 2027-04-03Direct0 Reported balance After 2022-06-21 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2022-06-21 · Disposition to issuer · Disposed 10,512 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.55 · Expires 2027-07-03Direct0 Reported balance After 2022-06-21 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2022-06-21 · Disposition to issuer · Disposed 9,678 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.76 · Expires 2027-10-02Direct0 Reported balance After 2022-06-21 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2022-06-21 · Disposition to issuer · Disposed 9,169 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.43 · Expires 2028-01-02Direct0 Reported balance After 2022-06-21 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2022-06-21 · Disposition to issuer · Disposed 7,697 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.07 · Expires 2028-04-02Direct0 Reported balance After 2022-06-21 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2022-06-21 · Disposition to issuer · Disposed 4,770 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.65 · Expires 2028-07-02Direct0 Reported balance After 2022-06-21 transaction · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · 2022-06-21 · Disposition to issuer · Disposed 3,871 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.01 · Expires 2028-10-01Direct0 Reported balance After 2022-06-21 transaction · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · 2022-06-21 · Disposition to issuer · Disposed 3,319 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.89 · Expires 2029-01-02Direct0 Reported balance After 2022-06-21 transaction · row 14 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 14 · 2022-06-21 · Disposition to issuer · Disposed 4,285 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.57 · Expires 2029-04-01Direct0 Reported balance After 2022-06-21 transaction · row 15 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 15 · 2022-06-21 · Disposition to issuer · Disposed 3,684 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.65 · Expires 2029-07-01Direct0 Reported balance After 2022-06-21 transaction · row 16 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 16 · 2022-06-21 · Disposition to issuer · Disposed 2,846 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.05 · Expires 2029-10-01Direct0 Reported balance After 2022-06-21 transaction · row 17 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 17 · 2022-06-21 · Disposition to issuer · Disposed 4,025 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.69 · Expires 2030-01-02Direct0 Reported balance After 2022-06-21 transaction · row 18 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 18 · 2022-06-21 · Disposition to issuer · Disposed 2,851 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.41 · Expires 2030-04-01Direct0 Reported balance After 2022-06-21 transaction · row 19 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 19 · 2022-06-21 · Disposition to issuer · Disposed 4,542 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.75 · Expires 2030-05-28Direct0 Reported balance After 2022-06-21 transaction · row 20 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 20 · 2022-06-21 · Disposition to issuer · Disposed 30,813 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F3: Option was granted under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.78 · Expires 2030-07-01Direct0 Reported balance After 2022-06-21 transaction · row 21 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 21 · 2022-06-21 · Disposition to issuer · Disposed 3,249 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.54 · Expires 2030-10-01Direct0 Reported balance After 2022-06-21 transaction · row 22 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 22 · 2022-06-21 · Disposition to issuer · Disposed 2,186 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.49 · Expires 2031-01-04Direct0 Reported balance After 2022-06-21 transaction · row 23 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 23 · 2022-06-21 · Disposition to issuer · Disposed 1,625 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.98 · Expires 2031-04-01Direct0 Reported balance After 2022-06-21 transaction · row 24 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 24 · 2022-06-21 · Disposition to issuer · Disposed 1,490 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.46 · Expires 2031-07-01Direct0 Reported balance After 2022-06-21 transaction · row 25 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 25 · 2022-06-21 · Disposition to issuer · Disposed 1,660 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F5: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option will vest in one installment on July 1, 2022.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.57 · Expires 2031-10-01Direct0 Reported balance After 2022-06-21 transaction · row 26 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 26 · 2022-06-21 · Disposition to issuer · Disposed 1,649 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F6: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option will vest in one installment on October 1, 2022.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.70 · Expires 2032-01-03Direct0 Reported balance After 2022-06-21 transaction · row 27 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 27 · 2022-06-21 · Disposition to issuer · Disposed 1,424 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F7: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option will vest in one installment on January 3, 2023.

Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.69 · Expires 2032-04-01Direct0 Reported balance After 2022-06-21 transaction · row 28 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 28 · 2022-06-21 · Disposition to issuer · Disposed 1,965 · Balance 0

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F8: Option was granted in lieu of retainer fees of $22,500 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option will vest in one installment on April 1, 2023.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2022-06-21 transaction · row 29 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 29 · 2022-06-21 · Disposition to issuer · Disposed 6,039 · Balance 0

F9: Each RSU represents a contingent right to receive one share of the Company's common stock.

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F10: The RSUs will vest in one annual installment on May 27, 2023.

Filing footnotes · ownership attribution and instrument terms

F1: On June 21, 2022, pursuant to the Transaction Agreement and Plan of Merger, dated as of January 9, 2022, by and among R1 RCM Holdco Inc. (f/k/a R1 RCM Inc.) (the "Company"), R1 RCM Inc. (f/k/a Project Roadrunner Parent Inc.) ("New R1"), Project Roadrunner Merger Sub Inc. ("R1 Merger Sub"), CoyCo 1, L.P., CoyCo 2, L.P. and certain other parties, R1 Merger Sub was merged with and into the Company, with the Company surviving as a direct, wholly owned subsidiary of New R1 (the "Reorganization").

F2: Upon consummation of the Reorganization, each share of the Company's common stock issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding share of common stock of New R1 and the Company's stockholders became stockholders of New R1. In addition, each restricted stock unit ("RSU") and option to purchase shares of common stock of the Company issued and outstanding immediately prior to the Reorganization was automatically exchanged into an equivalent corresponding RSU or option to purchase shares of common stock of New R1, subject to the same terms and conditions (including applicable vesting terms) as were applicable to RSUs or options to purchase shares immediately prior to the consummation of the Reorganization.

F3: Option was granted under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

F4: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option is fully vested.

F5: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option will vest in one installment on July 1, 2022.

F6: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option will vest in one installment on October 1, 2022.

F7: Option was granted in lieu of retainer fees of $15,000 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option will vest in one installment on January 3, 2023.

F8: Option was granted in lieu of retainer fees of $22,500 under a stock incentive plan, in a transaction exempt under Rule 16(b)-3. The option will vest in one installment on April 1, 2023.

F9: Each RSU represents a contingent right to receive one share of the Company's common stock.

F10: The RSUs will vest in one annual installment on May 27, 2023.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

R1 RCM Inc. /DE

Report date November 19, 2024 · Filed November 19, 2024

Section 16 reporting ended · disclosed 2024-11-19. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2024-11-19 transaction · row 1
1 source row

Row 1 · 2024-11-19 · Disposition to issuer · Disposed 87,765 · Balance 0

F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated July 31, 2024, by and among the Issuer, Raven Acquisition Holdings, LLC ("Parent") and Project Raven Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), at the time of the Merger (the "Effective Time") the reported securities were disposed of, with 72,114 shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), cancelled and converted into the right to receive $14.30 per share in cash without interest (the "Merger Consideration").

F2: Represents 15,651 shares of Common Stock of the Issuer underlying restricted stock units ("RSUs") of the Issuer which, pursuant to the Merger Agreement, were, at the Effective Time, automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (a) the number of shares of Common Stock subject to such RSUs as of immediately prior to the Effective Time and (b) the Merger Consideration.

Director Stock Option (right to buy)SEC Table II · derivative / convertible securityDirect0 Reported balance After 2024-11-19 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2024-11-19 · Disposition to issuer · Disposed 515,715 · Balance 0

F3: Each outstanding option to purchase Common Stock ("Options") held by the Reporting Person that was outstanding and unexercised immediately prior to or upon the Effective Time, whether vested or unvested, was, at the Effective Time, automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (a) the number of shares of Common Stock subject to such Option and (b) the amount by which the Merger Consideration exceeds the applicable per share exercise price of such Option, with any Options that have a per share exercise price equal to or exceeding the Merger Consideration being cancelled for no consideration as of the Effective Time.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to and in connection with the transactions contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated July 31, 2024, by and among the Issuer, Raven Acquisition Holdings, LLC ("Parent") and Project Raven Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), at the time of the Merger (the "Effective Time") the reported securities were disposed of, with 72,114 shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock"), cancelled and converted into the right to receive $14.30 per share in cash without interest (the "Merger Consideration").

F2: Represents 15,651 shares of Common Stock of the Issuer underlying restricted stock units ("RSUs") of the Issuer which, pursuant to the Merger Agreement, were, at the Effective Time, automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (a) the number of shares of Common Stock subject to such RSUs as of immediately prior to the Effective Time and (b) the Merger Consideration.

F3: Each outstanding option to purchase Common Stock ("Options") held by the Reporting Person that was outstanding and unexercised immediately prior to or upon the Effective Time, whether vested or unvested, was, at the Effective Time, automatically cancelled and converted into the right to receive an amount in cash (without interest and subject to applicable withholding taxes) equal to the product of (a) the number of shares of Common Stock subject to such Option and (b) the amount by which the Merger Consideration exceeds the applicable per share exercise price of such Option, with any Options that have a per share exercise price equal to or exceeding the Merger Consideration being cancelled for no consideration as of the Effective Time.

SeaSpine Holdings Corp

Report date January 05, 2023 · Filed January 10, 2023

Section 16 reporting ended · disclosed 2023-01-10. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2023-01-05 transaction · row 1
1 source row

Row 1 · 2023-01-05 · Disposition to issuer · Disposed 82,654 · Balance 0

F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 34,408 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2025-08-01Direct0 Reported balance After 2023-01-05 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2023-01-05 · Disposition to issuer · Disposed 58,559 · Balance 0

F3: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share.

F2: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.18 · Expires 2026-01-01Direct0 Reported balance After 2023-01-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2023-01-05 · Disposition to issuer · Disposed 3,858 · Balance 0

F5: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share.

F4: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.99 · Expires 2026-06-07Direct0 Reported balance After 2023-01-05 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2023-01-05 · Disposition to issuer · Disposed 13,920 · Balance 0

F7: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share.

F6: The option vests in four equal installments on each of September 7, 2016, December 7, 2016, March 7, 2017 and June 7, 2017.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 34,408 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.

F2: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter.

F3: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share.

F4: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.

F5: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share.

F6: The option vests in four equal installments on each of September 7, 2016, December 7, 2016, March 7, 2017 and June 7, 2017.

F7: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 03, 2016 Filed Oct 5, 2016 23:16 UTC R1 RCM Holdco Inc. ACHI · Entity 125898 GrantDirector Stock Option (right to buy) · Derivative 13,762 $1.09 Strike: $2.42 $15,000.58
Disclosure

SEC source: 0001472595-16-000261 · wf-form4_147570939292062.xml · derivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,762

Underlying: Common Stock · 13,762 shares

Expires 2026-10-03

F1 · price: This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.

Read SEC document
October 01, 2016 Filed Oct 4, 2016 17:52 UTC LUMOS PHARMA, INC. (NLNK) · Entity 85102 Tax withholdingCommon Stock 2,789 $15.02 $41,890.78
Disclosure

SEC source: 0001126234-16-000306 · wf-form4_147561794474682.xml · nonDerivative · entry 1

HENNEMAN JOHN B III · CIK 0001187572 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,099

F1 · shares: Represents shares of Common Stock withheld by the Issuer in satisfaction of its tax withholding obligation with respect to the vesting of 10,197 previously reported restricted stock units ("RSUs") granted to the Reporting Person.

F2 · balance_after: Includes 20,395 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on October 1, 2017, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

F3 · balance_after: Includes 1,500 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on January 2, 2017, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

F4 · balance_after: Includes 16,201 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on January 4, 2017, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.